03/12/2025
3:24 PM | FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
3:29 PM | FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:32 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:11 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
7:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
4:43 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:47 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:40 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:00 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:50 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:31 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/05/2025
3:31 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:07 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
8:24 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:27 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:59 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:31 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:36 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:51 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:54 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
8:09 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
6:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
11:10 AM | JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
4:12 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:18 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:07 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:03 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:00 PM | Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
5:00 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
5:00 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
5:00 PM | Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
6:05 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:08 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:10 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
4:30 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
4:30 PM | Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
4:30 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:50 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:46 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:16 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:10 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) Tesla doesn't pay a traditional dividend....
But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla…
Which could put up to $7,013 in your pocket every month… Click here to discover the new #1 way to invest in Tesla |
11/22/2024
3:30 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:30 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:18 PM | Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:30 AM | Madrigal Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
11/08/2024
4:07 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:01 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:47 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:32 PM | Madrigal Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/31/2024
8:02 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
6:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
7:36 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
8:51 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
8:29 PM | Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
7:16 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
6:52 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
7:58 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
8:46 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:41 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:42 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:42 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:45 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:03 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:28 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
8:39 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
8:44 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:17 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:37 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
8:45 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:53 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:03 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:39 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2024
5:48 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
8:36 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
8:53 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | Madrigal Pharmaceuticals (Filer)
| Form S-3ASR | |
05/07/2024
8:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:49 PM | Madrigal Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
7:50 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
7:53 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
7:50 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
7:50 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:41 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:44 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:47 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:22 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:21 PM | BAKER BROS. ADVISORS LP (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:28 PM | BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/21/2024
3:30 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
A brutally honest economic warning for 2025 (see proof) (Ad) New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says.... Full details here. |
03/20/2024
3:11 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
